Europe's PRAC starts review of fusafungine

14 September 2015 - Deborah Wilkes

Archived

The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the safety and benefit-risk balance of nasal and mouth sprays containing the antibiotic fusafungine.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: